Cargando…

Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury

BACKGROUND: Interleukin 6 (IL-6) is a predictive factor of poor prognosis in patients with acute respiratory distress syndrome (ARDS). However, its acute pulmonary hemodynamic effects and role in lung injury have not been investigated in a clinically relevant murine model of ARDS. METHODS: We used a...

Descripción completa

Detalles Bibliográficos
Autores principales: Voiriot, Guillaume, Razazi, Keyvan, Amsellem, Valérie, Tran Van Nhieu, Jeanne, Abid, Shariq, Adnot, Serge, Mekontso Dessap, Armand, Maitre, Bernard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397701/
https://www.ncbi.nlm.nih.gov/pubmed/28424078
http://dx.doi.org/10.1186/s12931-017-0553-6
_version_ 1783230316992790528
author Voiriot, Guillaume
Razazi, Keyvan
Amsellem, Valérie
Tran Van Nhieu, Jeanne
Abid, Shariq
Adnot, Serge
Mekontso Dessap, Armand
Maitre, Bernard
author_facet Voiriot, Guillaume
Razazi, Keyvan
Amsellem, Valérie
Tran Van Nhieu, Jeanne
Abid, Shariq
Adnot, Serge
Mekontso Dessap, Armand
Maitre, Bernard
author_sort Voiriot, Guillaume
collection PubMed
description BACKGROUND: Interleukin 6 (IL-6) is a predictive factor of poor prognosis in patients with acute respiratory distress syndrome (ARDS). However, its acute pulmonary hemodynamic effects and role in lung injury have not been investigated in a clinically relevant murine model of ARDS. METHODS: We used adult C57Bl6 wild-type (WT) and IL-6 knock-out (IL-6KO) mice. The animals received intravenous recombinant human IL-6 (rHuIL-6) or vehicle followed by intratracheal lipopolysaccharide (LPS) or saline before undergoing low tidal volume mechanical ventilation (MV) for 5 h. Before sacrifice, right ventricular systolic pressure and cardiac output were measured and total pulmonary resistance was calculated. After sacrifice, lung inflammation, edema and injury were assessed with bronchoalveolar lavage (BAL) and histology. In other experiments, right ventricular systolic pressure was recorded during hypoxic challenges in uninjured WT mice pretreated with rHuIL-6 or rHuIL-6 + non-selective nitric oxide synthase inhibitor L-NAME or vehicle. RESULTS: IL-6KO((LPS+MV)) mice showed a faster deterioration of lung elastic properties and more severe bronchoalveolar cellular inflammation as compared to WT((LPS+MV)). Treatment with rHuIL-6 partially prevented this lung deterioration. Total pulmonary resistance was higher in IL-6KO((LPS+MV)) mice and this increase was abolished in rHuIL-6-treated IL-6KO mice. Finally, rHuIL-6 reduced hypoxic pulmonary vasoconstriction in uninjured WT mice, an effect that was abolished by co-treatment with L-NAME. CONCLUSIONS: In a double-hit murine model of ARDS, IL-6 deficient mice experienced more severe bronchoalveolar cellular inflammation as compared to wild-type littermates. Furthermore, IL-6 deficiency caused marked acute pulmonary hypertension, which may be, at least partially, due to vasoactive mechanisms. A dysregulation of nitric oxide synthase may account for this observation, a hypothesis that will need to be investigated in future studies.
format Online
Article
Text
id pubmed-5397701
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53977012017-04-20 Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury Voiriot, Guillaume Razazi, Keyvan Amsellem, Valérie Tran Van Nhieu, Jeanne Abid, Shariq Adnot, Serge Mekontso Dessap, Armand Maitre, Bernard Respir Res Research BACKGROUND: Interleukin 6 (IL-6) is a predictive factor of poor prognosis in patients with acute respiratory distress syndrome (ARDS). However, its acute pulmonary hemodynamic effects and role in lung injury have not been investigated in a clinically relevant murine model of ARDS. METHODS: We used adult C57Bl6 wild-type (WT) and IL-6 knock-out (IL-6KO) mice. The animals received intravenous recombinant human IL-6 (rHuIL-6) or vehicle followed by intratracheal lipopolysaccharide (LPS) or saline before undergoing low tidal volume mechanical ventilation (MV) for 5 h. Before sacrifice, right ventricular systolic pressure and cardiac output were measured and total pulmonary resistance was calculated. After sacrifice, lung inflammation, edema and injury were assessed with bronchoalveolar lavage (BAL) and histology. In other experiments, right ventricular systolic pressure was recorded during hypoxic challenges in uninjured WT mice pretreated with rHuIL-6 or rHuIL-6 + non-selective nitric oxide synthase inhibitor L-NAME or vehicle. RESULTS: IL-6KO((LPS+MV)) mice showed a faster deterioration of lung elastic properties and more severe bronchoalveolar cellular inflammation as compared to WT((LPS+MV)). Treatment with rHuIL-6 partially prevented this lung deterioration. Total pulmonary resistance was higher in IL-6KO((LPS+MV)) mice and this increase was abolished in rHuIL-6-treated IL-6KO mice. Finally, rHuIL-6 reduced hypoxic pulmonary vasoconstriction in uninjured WT mice, an effect that was abolished by co-treatment with L-NAME. CONCLUSIONS: In a double-hit murine model of ARDS, IL-6 deficient mice experienced more severe bronchoalveolar cellular inflammation as compared to wild-type littermates. Furthermore, IL-6 deficiency caused marked acute pulmonary hypertension, which may be, at least partially, due to vasoactive mechanisms. A dysregulation of nitric oxide synthase may account for this observation, a hypothesis that will need to be investigated in future studies. BioMed Central 2017-04-19 2017 /pmc/articles/PMC5397701/ /pubmed/28424078 http://dx.doi.org/10.1186/s12931-017-0553-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Voiriot, Guillaume
Razazi, Keyvan
Amsellem, Valérie
Tran Van Nhieu, Jeanne
Abid, Shariq
Adnot, Serge
Mekontso Dessap, Armand
Maitre, Bernard
Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury
title Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury
title_full Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury
title_fullStr Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury
title_full_unstemmed Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury
title_short Interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury
title_sort interleukin-6 displays lung anti-inflammatory properties and exerts protective hemodynamic effects in a double-hit murine acute lung injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397701/
https://www.ncbi.nlm.nih.gov/pubmed/28424078
http://dx.doi.org/10.1186/s12931-017-0553-6
work_keys_str_mv AT voiriotguillaume interleukin6displayslungantiinflammatorypropertiesandexertsprotectivehemodynamiceffectsinadoublehitmurineacutelunginjury
AT razazikeyvan interleukin6displayslungantiinflammatorypropertiesandexertsprotectivehemodynamiceffectsinadoublehitmurineacutelunginjury
AT amsellemvalerie interleukin6displayslungantiinflammatorypropertiesandexertsprotectivehemodynamiceffectsinadoublehitmurineacutelunginjury
AT tranvannhieujeanne interleukin6displayslungantiinflammatorypropertiesandexertsprotectivehemodynamiceffectsinadoublehitmurineacutelunginjury
AT abidshariq interleukin6displayslungantiinflammatorypropertiesandexertsprotectivehemodynamiceffectsinadoublehitmurineacutelunginjury
AT adnotserge interleukin6displayslungantiinflammatorypropertiesandexertsprotectivehemodynamiceffectsinadoublehitmurineacutelunginjury
AT mekontsodessaparmand interleukin6displayslungantiinflammatorypropertiesandexertsprotectivehemodynamiceffectsinadoublehitmurineacutelunginjury
AT maitrebernard interleukin6displayslungantiinflammatorypropertiesandexertsprotectivehemodynamiceffectsinadoublehitmurineacutelunginjury